François Marceau
- Formation
-
M.D.
Ph.D.
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Infectiologie et immunologie
- Adresse
- 2705, boulevard Laurier, T-1-49
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-525-4444, poste 46155
- Télécopieur
- +1 418-654-2765
- Courriel
- francois.marceau@crchul.ulaval.ca
Médiateurs peptidiques de l’inflammation : le système kallikréine-kinines et les récepteurs des peptides apparentés à la bradykinine
Séquestration des médicaments aminés dans les compartiments acides de la cellule: conséquences pour la sécurité et l’efficacité de médicaments retrouvés dans de multiples classes thérapeutiques
Séquestration des médicaments aminés dans les compartiments acides de la cellule: conséquences pour la sécurité et l’efficacité de médicaments retrouvés dans de multiples classes thérapeutiques
Publications récentes (voir toutes les publications de ce chercheur)
Gera L, Roy C, Bawolak MT, Charest-Morin X, Marceau F. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: Structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes. Peptides,
2012. Epub
Bawolak MT, Lodge R, Morissette G, Marceau F. Bradykinin B receptor-mediated transport into intact cells: anti-receptor antibody-based cargoes. European journal of pharmacology,
2011. 668: 107-14
Morissette G, Bawolak MT, Marceau F. Dissociation of the vacuolar and macroautophagic cytopathology from the cytotoxicity induced by the lipophilic local anesthetic bupivacaine. Canadian journal of physiology and pharmacology,
2011. 89: 505-12
Gera L, Roy C, Bawolak MT, Bouthillier J, Adam A, Marceau F. Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue. Pharmacological research : the official journal of the Italian Pharmacological Society,
2011. 64: 528-34
Roy C, Marceau E, Gera L, Marceau F. An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B(1) receptor in response to angiotensin converting enzyme inhibition. Vascular pharmacology,
2011. Epub
Bawolak MT, Roy C, Gera L, Marceau F. Prolonged signalling and trafficking of the bradykinin B(2) receptor stimulated with the amphibian peptide maximakinin: Insight into the endosomal inactivation of kinins. Pharmacological research : the official journal of the Italian Pharmacological Society,
2011. Epub
Marceau F, Bawolak MT, Lodge R, Bouthillier J, Gagne-Henley A, C-Gaudreault R, Morissette G. Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs. Toxicology and applied pharmacology,
2011. Epub
Marceau F. Drugs in the kallikrein-kinin system In: Bader M, ed. Kinins Berlin: De Gruyter, 2011. p.69-84.
Gera L, Bawolak MT, Roy C, Lodge R, Marceau F. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme. The Journal of pharmacology and experimental therapeutics,
2011. 337: 33-41
Marceau F, Deblois D, Petitclerc E, Levesque L, Drapeau G, Audet R, Godin D, Larrivee JF, Houle S, Sabourin T, Fortin JP, Morissette G, Gera L, Bawolak MT, Koumbadinga GA, Bouthillier J. Vascular smooth muscle contractility assays for inflammatory and immunological mediators. International immunopharmacology,
2010. 10: 1344-53
